AJA. Z. Jamalova

A. Z. Jamalova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. Z. Jamalova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • M. B. Musaev

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV” (VNIIP – FSC VIEV)

    5 shared publications
  • Salavat Samadovich Khalikov

    Federal State Budgetary Institution of Science A. N. Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences

    2 shared publications
  • V. V. Zashchepkina

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV” (VNIIP – FSC VIEV)

    2 shared publications
  • A. Khalimov

    Nursery for semi-wild deer at the summer residence of the head of the Chechen Republic R.A. Kadyrov

    1 shared publication
  • E. E. Belova

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV” (VNIIP – FSC VIEV)

    1 shared publication
  • I. A. Kravchenko

    Federal State Budgetary Educational Institution of Higher Education «Samara State Agrarian University

    1 shared publication

Latest Publications

  • Open Access

    Toxicological evaluation of a supramolecular soliddispersed complex preparation based on ivermectin and praziquantel substances

    by I. Kh. Shakhbiev, M. B. Musaev, A. Z. Jamalova, И. Х. Шахбиев, М. Б. Мусаев, А. З. Джамалова

    The purpose of the research is to conduct toxicological studies to establish the safety of a new supramolecular soliddispersed complex of ivermectin and praziquantel (SKIP) and determine the potential risk of animal mortality. Materials and methods. Acute oral toxicity was studied in the vivarium of the All-Russian Research Institute of Infectious Diseases (VNIIP), a branch of the All-Russian Scientific Center for Experimental and Experimental Veterinary Sciences (RAS). Cutaneous toxicity, effects on the ocular mucosa, and assessment of the local irritant effect of SKIP and its constituents were studied in the Biological Research Department of the Laboratory of Ecological and Genetic Monitoring of Living Systems (Kh. I. Ibragimov Research Institute, RAS, Grozny). Results. The acute oral toxicity of SKIP was determined to be LD 50 of 9242.2±1633.3 (7608.9÷10875.5) mg/kg for rats and 8921.3±623.3 (8297.9÷9544.6) mg/kg for mice. According to GOST 12.1.007-76, based on acute oral toxicity testing in outbred white rats and mice, SKIP is classified as a low-hazard substance (hazard class 4). Based on acute dermal toxicity testing, 25,000 mg/kg of SKIP was found to be the maximum possible dose when applied to the skin of rats. Based on acute dermal toxicity testing, SKIP is also classified as a low-hazard substance (hazard class 4) and has no adverse effects on intact skin. Conjunctival hyperemia was observed in rabbits when SKIP was administered intraconjunctivally. When assessing the local irritant effect of SKIP, after 3 weeks, the clipped areas at the application site were covered with hair, indicating the lack of irritant properties of SKIP after a single application to the skin.

  • Open Access

    Testing ivermectin-based solid dispersion preparations obtained by different techniques against parasitic diseases of domestic animals

    by M. B. Musaev, I. Kh. Shakhbiev, A. Z. Jamalova

    The purpose of the research is to develop the production of ivermectin-based complex solid dispersion preparations with water-soluble polymer fillers using the technique previously developed in the VNIIP – FSC VIEV with a solvent, as well as the INEOS RAS (Nesmeyanov Institute of Organoelement Compounds RAS) technique in one stage without involving liquid phases, and their comparative performance testing against parasitosis of animals.Materials and methods. Preparation 1 was developed using the technique developed in the VNIIP – FSC VIEV in several stages, and preparation 2 was developed using the INEOS RAS technique in one stage. A comparative performance test of the above preparations was conducted on three private Chechen Republic farms on 870 Tushino sheep and 57 local goats spontaneously infected with gastrointestinal Strongylata. In the first experiment, the sheep (n = 130) were divided into 4 groups of 30–35 animals each on the analog principle. The sheep from the first and second experimental groups were given preparations 1 and 2 orally in the suspension formulation at doses of 0.2 mg/kg by active substance. The third and fourth groups of 35 sheep each were treated with the same preparations mixed with combined feed at the same dose, by the group method only. In the second experiment, 140 sheep and 57 goats were treated once, individually, with preparation 1 at a dose of 0.2 mg/kg in the suspension formulation. The third experiment on testing preparation 1 was conducted on 600 sheep, 217 bull calves, 165 horses, and 15 dogs in production conditions.Results and discussion. The solubility of preparation 1 increased by 7.1, and preparation 2 by 4.7. A HPLC analysis confirmed 95.0% preservation of ivermectin in both preparations. One hundred percent efficacy against gastrointestinal nematodes in sheep was confirmed for preparations 1 and 2 obtained by different techniques, given individually, once, at a dose of 0.2 mg/kg in the suspension formulation. The treating of the sheep with preparation 1 mixed with combined feed by group feeding obtained 100% efficacy, and 94.6% for preparation 2. The deworming of the sheep in the second experiment showed 100% efficiency for preparation 1 given individually, once, at a dose of 0.2 mg/kg by active substance in the suspension formulation. The testing of complex preparation 1 at a dose of 0.2 mg/kg in the third experiment obtained 100% efficacy against gastrointestinal nematodes in horses, young cattle, sheep, goats, and dogs. No side effects were observed in the animals after deworming.

  • Open Access

    Testing of the supramolecular complex of ivermectin Aniverm-2.0% against gastro-intestinal strongylatosis of marals, sika deer and roe deer

    by I. Kh. Shahbiev, M. B. Musaev, A. Z. Jamalova, I. A. Kravchenko, V. V. Zashchepkina, A. Khalimov

    The purpose of the research is to test the supramolecular complex of ivermectin Aniverm-2.0% by free feeding of the drug mixed with concentrated feed against gastro-intestinal strongylatosis of the deer.Materials and methods. The test of the supramolecular complex of ivermectin Aniverm-2.0% against gastro-intestinal strongylatosis of semi-wild animals was carried out from November 2023 to April 2024 in the reserve of the country residence of the head of the Chechen Republic, where more than 200 marals, sika deer and roe deer were kept. 40 fresh fecal samples were collected from the ground in December 2023. The fecal samples were examined in the biology laboratory of the Ibragimov Integrated Research Institute of the Russian Academy of Sciences by the Fülleborn flotation method using a saturated sodium chloride solution and the method of successive washes to detect elaphostrongyl larvae. Aniverm-2.0% was fed at a dose of 0.3 mg/kg mixed with concentrated feed by the group method; evenly poured into 4 feeders for 200 deer. The efficacy of the drug was taken into account by the "critical test" after 10 days and 4 months after deworming.Results and discussion. In the feces of deer, strongylata eggs were found in 23 out of 40 samples (EI = 57.5%) with an average of 88.9±2.74 egg sp. detected in 1 g of feces. Elaphostrongyl larvae were not detected. Dicrocoelium spp. eggs were found in 8 samples. After deworming of marals, red deer and roe deer with Aniverm-2.0% at a dose of 0.3 mg/kg by active ingredient (0.15 mg/kg by the drug) by the group method mixed with compound feed, strongylata eggs of the digestive tract were not found in the feces after 10 days and for 4 months after treatment. 100% therapeutic and prophylactic efficacy of the drug was established. The animals willingly ate the drug with food, no side effects were noted after administration of the drug.

  • Open Access

    Testing of the supramolecular complex of ivermectin Aniverm-2.0% against parasitosis on various types of livestock animals

    by M. B. Musaev, V. V. Zashchepkina, E. E. Belova, S. S. Khalikov, A. Z. Dzhamalova, I. H. Shahbiev

    The purpose of the research is to obtain and test a complex drug Aniverm-2.0% based on the ivermectin substance by free feeding in a mixture with concentrated feed against parasitosis of cattle, sheep, and horses.Materials and methods. Aniverm-2.0% obtained by mechanochemical technology was tested on a farm in the Shatoy Region, the Chechen Republic, on 900 sheep, 180 cattle and 156 horses in March-April 2023. To determine the infection rate, coproovoscopic examinations were conducted on 80 samples from sheep, 20 samples from young cattle and 30 samples from horses using the Fulleborn’s flotation method with a saturated sodium chloride solution. Sheep were dewormed using a group method. The drug was mixed with feed per 0.3 mg/kg for the AS or 60 mg for the drug per animal. The young cattle were kept by tie-up housing and therefore they were given Aniverm-2.0% once at a dose of 0.2 mg/kg for the AS individually in a mixture with feed. The horses were given the drug in a group method at a dose of 0.2 mg/kg for the AS or 1.5 mg/kg for the drug. Fecal samples from all animals were examined before and 2 weeks after the drug.Results and discussion. A 100% rate of infection of the sheep by gastrointestinal nematodes (Strongylata, Nematodirus spp., Trichocephalus spp.) was determined with an average number of eggs 633.3 in 1 g of feces. In 20 fecal samples from the young cattle, 16 were found to have Strongylata eggs (prevalence = 80.0%) with 222.2–280.5 specimens of Strongylata eggs found in 1 g of feces. Strongylata eggs were found in all 30 examined fecal samples from the horses, on average, 253.3 specimens/g of feces (100%). At 2 weeks after treatment, nematode eggs were found in three out of 80 examined fecal samples from the sheep, which can be explained that the sheep did not eat the appropriate dose of the drug. The drug efficacy was determined to be 99.7%. One hundred percent efficacy of the drug was obtained on young cattle and horses.


  • Open Access

    Solid dispersion complex triclabendazole preparations with succinic acid and their fasciolocidal activity

    by M. B. Musaev, M. S. Khalikov, A. Z. Dzhamalova, M. M. Ilyin, S. S. Khalikov

    The purpose of the research is to test the efficacy of triclafascid and two solid dispersion complex preparations based on the triclabendazole substance against fasciolosis in cattle and sheep. Materials and methods. Complex preparations of triclabendazole (TCB) formulations: Succinic Acid (SA): Polyvinylpyrrolidone (PVP) (1: 1 : 8) and TCB: SA: Arabinogalactan (AG) (1: 1 : 8) were obtained by combined solid-stategrinding of the components in a fiber drum on an LE-101 ball mill at a roll rotation speed of 60 rpm with a process module of 1: 17 for 1 to 6 hours with sampling for analysis (HPLC) for changes in the TCB solubility. A comparative test of the efficacy of triclafascid and new solid dispersions (SD) of TCB complexes with SA against fascioliasis of sheep and cattle was conducted in the North-Eastern Federal District of the Caucasus in March-April 2023. To determine the Fasciola infection rate in animals, fecal samples were individually taken and examined by the Fülleborn methods using saturated aqueous NaCL solution and sequential washing. The drug efficacy was recorded at 25-30 days after deworming in analogy with "critical test". The results were statistically processed by the Student-Fisher method using Microsoft Excel 2007. Results and discussion. The resulting TCB and SA complexes with polymers had an increased solubility (up to 59–70 times) that depended on the polymer nature. The efficacy of new TCB dosage forms against fascioliasis in sheep at a dose of 1.5 mg/kg, i.e. 0.5 mg/kg less than the therapeutic dose as compared with oral triclafascid was 90.0 and 100%, respectively, and 85.7% in cattle at a dose of 2.0 mg/kg for the active substance.